Hypertension, commonly known as high blood pressure, affects over 1.28 billion people worldwide, making it one of the most prevalent chronic health conditions. Despite advancements in medications and lifestyle interventions, many patients struggle to achieve optimal blood pressure control, particularly those with resistant hypertension. As researchers explore innovative approaches to managing this condition, gene therapy has emerged as a promising frontier. By targeting the genetic mechanisms underlying hypertension, gene-based therapies offer the potential for more precise and long-lasting treatment. This article examines the science behind gene therapy for hypertension, the experimental therapies under development, and the potential challenges and future prospects of this cutting-edge approach.
Tag Archives: CRISPR
Hypertension, or high blood pressure, is a global health crisis, affecting over 1.28 billion adults and contributing to millions of deaths annually through complications like heart disease, stroke, and kidney failure. While lifestyle changes and medications can manage the condition, they rarely address the underlying genetic predispositions that contribute to hypertension. Recent advancements in genetic science, particularly CRISPR-Cas9 gene editing technology, offer new hope for tackling the root causes of this pervasive condition. This article explores the potential of CRISPR technology to revolutionize hypertension treatment by targeting its genetic roots, the challenges involved, and the ethical considerations of applying gene editing in this context.